ARCHIVES

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

This article is from The Cancer Letter archive.

Vol. 20 No. 43 | November 11, 1994

Download PDF Visit The Full Archive

Related Articles

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Unscreened Women At High Risk of Breast Cancer

October 29, 2004

Idaho Senator Pressure DeVita On Taking Neutron Facility

May 6, 1988

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988

In Brief: Community Outreach Planning Grants Still Open; Study Section Meetings May Be Opened By Courts

October 18, 1974